Panretin (Eisai Inc.)


Welcome to the PulseAid listing for the Panretin drug offered from Eisai Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eisai Inc.
NON-PROPRIETARY NAME: Alitretinoin
SUBSTANCE NAME: ALITRETINOIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-02-03
END MARKETING DATE: 0000-00-00


Panretin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPanretin from Eisai Inc.
LABELER NAME: Eisai Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 60(mg/60g)
START MARKETING DATE: 2009-02-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62856-601_1fa61b94-6ae2-4edc-85e0-8936108bda19
PRODUCT NDC: 62856-601
APPLICATION NUMBER: NDA020886

Other ALITRETINOIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eisai Inc.Panretin